Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abbott
MedTech
Boston Scientific, Abbott tout long-term heart occluder data
Boston Scientific and Abbott both put forward studies supporting their respective implants for sealing off the heart’s left atrial appendage.
Conor Hale
Nov 19, 2024 12:00pm
Abbott posts positive, longer-term data for its Esprit BTK stent
Nov 5, 2024 11:00am
TCT: Abbott atherectomy study fails vs. balloon angioplasty
Oct 29, 2024 12:30pm
Abbott advances clinical studies in pulsed field ablation
Oct 11, 2024 2:00pm
Over-the-counter CGM market grows, with Abbott’s Lingo debut
Sep 5, 2024 12:00pm
Abbott begins neuromodulation trial in drug-resistant depression
Sep 4, 2024 11:02am
